Role of Molecular Imaging in Oncology
Journal Title: Cancer Studies & Molecular Medicine – Open Journal - Year 2014, Vol 1, Issue 1
Abstract
Molecular Imaging (MI) is an emerging technology for the early detection of disease, staging of the disease, and for monitoring response to therapy. It also offers a non-invasive method to detect in vivo biological functions and processes at a molecular level. The use of MI requires careful selection of targeting molecules which are expressed differentially in diseased vs. healthy cells to interrogate the cell microenvironment. Targeting molecules for MI could consist of small molecules, single amino acid units, low molecular weight peptides, antibodies or antibody fragments. Over the years, a large number of small molecular weight imaging probes have been developed to target different molecular pathways using Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT). The use of high molecular weight probes such as radioactive antibodies (Ab) is also equally attractive. While a major effort is placed on developing radioactive probes for PET and SPECT imaging, an intense effort is being focused on enhancing the utility of other MI modalities such as nuclear Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS), Computed Tomography (CT), optical imaging and ultrasound (US).
Authors and Affiliations
Pradeep K. Garg
Keywords
Related Articles
- EP ID EP552507
- DOI 10.17140/CSMMOJ-1-e001
- Views 114
- Downloads 0
Regulation in Cell Cycle via p53 and PTEN Tumor Suppressors
One of the target effectors of p53 transcription factor is the Phosphatase and Tensin homologue deleted on chromosome 10 (PTEN) which has protein phosphatase activity and lipid phosphatase activity that antagonizes PI3K...
Classifying Lung Adenocarcinoma and Squamous Cell Carcinoma using RNA-Seq Data
Background: Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are two primary subtypes of non-small cell lung carcinoma (NSCLC). Currently, the most widely used method to discriminate between LUAD and LU...
Elimination of Tumor Suppressor Proteins during Liver Carcinogenesis
Liver cancer is one of the most lethal cancers. Quiescent liver expresses up to 20 tumor suppressor proteins including Rb, p53, CCAAT-Enhancer-Binding Protein (C/EBP)α, Hepatocyte Nuclear Factor (HNF4)α and p16 and it is...
The Proportion of ALDEFLUOR-Positive Cancer Stem Cells Changes with Cell Culture Density Due to the Expression of Different ALDH Isoforms
A significant number of discrepancies exist within the literature regarding ALDEFLUOR-positive stem cell populations in cell lines. We hypothesized that these inconsistencies resulted from differences in culture conditio...
Dosimetric Characterization of an Abscopal Response in a Patient With Oligometastatic Melanoma Undergoing Concurrent Treatment With Pembrolizumab and Stereotactic Body Radiotherapy (SBRT)
Recently, preclinical and clinical evidence has shown that a synergy may exist between radiation and immune check-point therapies such as pembrolizumab. Radiation has been shown to activate the immune system, and in comb...